Potential function of granulysin, other related effector molecules and lymphocyte subsets in patients with TB and HIV/TB coinfection

International Journal of Medical Sciences

Volumn 10, Issue 8, 2013, Pages 1003-1014

  Pitabut, Nada ^a   Sakurada, Shinsaku ^b   Tanaka, Takahiro ^b   Ridruechai, Chutharut ^a   Tanuma, Junko ^b   Aoki, Takahiro ^b   Kantipong, Pacharee ^c   Piyaworawong, Surachai ^d   Kobayashi, Nobuyuki ^b   Dhepakson, Panadda ^e   Yanai, Hideki ^f   Yamada, Norio ^g   Oka, Shinichi ^b   Okada, Masaji ^h   Khusmith, Srisin ^a   Keicho, Naoto ^b  

^a MAHIDOL UNIVERSITY   (Thailand)

^b NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^c Chiang Rai Regional Hospital   (Thailand)

^d Mae Chan Hospital   (Thailand)

^e MINISTRY OF PUBLIC HEALTH   (Thailand)

^f Japan Anti Tuberculosis Association   (Thailand)

^g RESEARCH INSTITUTE OF TUBERCULOSIS   (Japan)

^h NATIONAL HOSPITAL ORGANIZATION KINKI CHUO CHEST MEDICAL CENTER   (Japan)

Author keywords

Granulysin; HIV; HIV TB coinfection; Lymphocytes subsets; TB

Indexed keywords

EFAVIRENZ; GAMMA INTERFERON; GRANULYSIN; GRANULYSIN 15KDA; GRANULYSIN 17KDA; GRANULYSIN 9KDA; GRANZYME B; ISOPROTEIN; LAMIVUDINE; NEVIRAPINE; PERFORIN; STAVUDINE; TUBERCULOSTATIC AGENT; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; COLITIS; CONTROLLED STUDY; DOUBLE NEGATIVE INVARIANT NATURAL KILLER T CELL; EFFECTOR CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRAPULMONARY TUBERCULOSIS; FEMALE; FLOW CYTOMETRY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOST RESISTANCE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LUNG TUBERCULOSIS; LYMPHOCYTE COUNT; LYMPHOCYTE SUBPOPULATION; MALE; MIXED INFECTION; NATURAL KILLER CELL; PROGNOSIS; PROTEIN BLOOD LEVEL; TUBERCULOUS LYMPHADENITIS; TUBERCULOUS MENINGITIS; VGAMMA9+ VDELTA2+ T CELL; WESTERN BLOTTING;

GRANULYSIN; HIV; HIV/TB COINFECTION; LYMPHOCYTES SUBSETS.; TB;

ADULT; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; BLOTTING, WESTERN; FEMALE; FLOW CYTOMETRY; HIV INFECTIONS; HUMANS; LYMPHOCYTE SUBSETS; MALE; MIDDLE AGED; TUBERCULOSIS;

EID: 84879304124     PISSN: 14491907     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijms.6437     Document Type: Article

References (38)

1. [Internet] WHO: Geneva, Switzerland. Global Tuberculosis report 2012. http://www.who.int/tb/publications/global_report/en/
2. Whalen C, Horsburgh CR, Hom D, Lahart C, Simberkoff M, Ellner J. Accelerated course of human immunodeficiency virus infection after tuberculosis. Am J Respir Crit Care Med. 1995; 151: 129-35.
3. Goletti D, Weissman D, Jackson RW, et al. Effect of Mycobacterium tuberculosis on HIV replication: role of immune activation. J Immunol. 1996; 157: 1271-8.
4. + T cells go out of stock. Nat Immunol. 2000; 1: 285-289.
5. Dietrich CR, Flynn JL. HIV-1/Mycobacterium tuberculosis Coinfection Immunology: How Does HIV-1 Exacerbate Tuberculosis? Infect Im-mun. 2011; 79: 1407-17.
6. Pena SV, Hanson DA, Carr BA, Goralski TJ, Krensky AM. Processing, subcellular localization and function of 519 (granulysin), a human late T cell activation molecule with homology to small, lytic, granule proteins. J Immunol. 1997; 158: 2680-8.
7. Krensky AM, Clayberger C. Biology and clinical relevance of granulysin. Tissue Antigens. 2009; 73: 193-8.
8. Hanson DA, Kaspar AA, Poulain FR, Krensky AM. Biosynthesis of granulysin, a novel cytolytic molecule. Mol Immunol. 1999; 36: 413-22.
9. Stenger S, Hanson DA, Teitelbaum R, et al. An antimicrobial activity of cytolytic T cells mediated by granulysin. Science. 1998; 282: 121-5.
10. Ogawa K, Takamori Y, Suzuki K, et al. Granulysin in human serum as a marker of cell mediated immunity. Eur J Immunol. 2003; 33: 1925-33.
11. Pena SV, Krensky AM. Granulysin, a new human cytolytic granule-associated protein with possible involvement in cell mediated cyto-toxicity. Semin Immunol. 1997; 9: 117-25.
12. Sahiratmadja E, Alisjahbana B, Buccheri S, et al. Plasma granulysin levels and cellular interferon-y production correlate with curative host responses in tuberculosis, while plasma interferon-y levels correlate with tuberculosis disease activity in adults. Tuberculosis. 2007; 87: 312-21.
13. Serbina NV, Lazarevic V, Flynn JL. CD4+ T cells are required for the development of cytotoxic CD8+ T cells during Mycobacterium tuberculosis infection. J Immunol. 2001; 167: 6911-7000.
14. Gansert JL, Kiessler V, Engele M, et al. Human NKT cells express granulysin and exhibit antimycobacterial activity. J Immunol. 2003; 170: 3154-61.
15. Mueller H, Faé KC, Magdorf K, et al. Granulysin-exp res sing CD4+ T cells as candidate immune marker for tuberculosis during childhood and adolescence. PLoS One. 2011; 6: e29367. doi: 10.1371/journal.pone.0029367
16. Montoya CJ, Cataño JC, Ramirez Z, Rugeles MT, Wilson SB, Landay AL. Invariant NKT cells from HIV-1 or Mycobacterium tuberculosis-infected patients express an activated phenotype. Clin Immunol. 2008; 127: 1-6.
17. Dieli F, Troye-Blomberg M, Ivanyi J, et al. Granulysin-dependent killing of intracellular and extracellular Mycobacterium tuberculosis by Vy9/V52 T lymphocytes. J Infect Dis. 2001; 184: 1082-5.
18. Andersson J, Samarina A, Fink J, Rahman S, Grundstro S. Impaired expression of perforin and granulysin in CD8+T cells at the site of infection in human chronic pulmonary tuberculosis. Infect Immun. 2007; 75: 5210-22.
19. Flynn JL, Chan J. Immunology of tuberculosis. Annu Rev Immunol. 2001; 19: 93-129.
20. Hammond AS, McConkey SJ, Hill PC, et al. Mycobacterial T cell responses in HIV-infected patients with advanced immunosuppression. J Infect Dis. 2008; 197: 295-9.
21. Geldmacher C, Schuetz A, Ngwenyama N, et al. Early Depletion of Mycobacterium tuberculosis-Specific T Helper 1 Cell Responses after HIV-1 Infection. J Infect Dis. 2008; 198: 1590-8.
22. Deveci F, Akbulut H, Turgut T, Muz MH. Changes in serum cytokine levels in active tuberculosis with treatment. Mediators Inflamm. 2005; 5: 256-62.
23. He XY, Xiao L, Chen HB, et al. T regulatory cells and Th1/Th2 cytokines in peripheral blood from tuberculosis patients. Eur J Clin Microbiol Infect Dis. 2010; 29: 643-50.
24. Di Liberto D, Buccheri S, Caccamo N, et al. Decreased serum granulysin levels in childhood tuberculosis which reverses after therapy. Tuberculosis. 2007; 87: 322-8.
25. Pitabut N, Mahasirimongkol S, Yanai H, et al. Decreased plasma granulysin and increased interferon-gamma concentrations in patients with newly diagnosed and relapsed tuberculosis. Microbiol Immunol. 2011; 55: 565-73.
26. Subramanyam S, Hanna LE, Venkatesan P, Sankaran K, Narayanan PR, Swaminathan S. HIV alters plasma and Mffr-induced cytokine production in patients with tuberculosis. J Interferon Cytokine Res. 2004; 24: 101-6.
27. Kawashima Y, Fukutomi T, Tomonaga T, et al. High-yield pep-tide-extraction method for the discovery of subnanomolar biomarkers from small serum samples. J Prot Res. 2010; 9: 1694-705.
28. Corbett EL, Watt CJ, Walker N, et al. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med. 2003; 163: 1009-21.
29. Toosi Z, Wu M, Islam N, Teixeira-Johnson L, Hejal R, Aung H. Transac-tivation of human immunodeficiency virus-1 in T-cells by Mycobacterium tuberculosis-infected mononuclear phagocytes. J Lab Clin Med. 2004; 144: 108-15.
30. Klingstrom J, Gudmundsdotter L, Zuber B, et al. Elevated levels of serum perforin in chronic HIV-1 and acute SIV/SHIV infection. AIDS. 2006; 20: 119-32.
31. Siawaya JFD, Bapela NB, Ronacher K, et al. Immune parameters as markers of tuberculosis extent of disease and early prediction of anti-tuberculosis chemotherapy response. J Infect. 2008; 56: 340-7.
32. Dlugovitzky D, Torres-Morales A, Rateni L, et al. Circulating profile of Th1 and Th2 cytokines in tuberculosis patients with different degrees of pulmonary involvement. FEMS Immunol Med Microbiol. 1997; 18: 203-7.
33. Serbina NV, Flynn J. Early emergence of CD8+ T cells primed for production of Type 1 cytokines in the lungs of Mycobacterium tuberculosis-infected mice. Infect Immun. 1999; 67: 980-8.
34. Schaible UE, Collins HL, Kaufmann SH. Confrontation between intra-cellular bacteria and the immune system. Adv Immunol. 1999; 71: 267-77.
35. Lawn SD, Bekker LG, Miller RF. Immune reconstitution disease associated with mycobacterial infections in HIV-infected individuals receiving antiretrovirals. Lancet Infect Dis. 2005; 5: 361-73.
36. Lawn SD. Tuberculosis and HIV co-infection. Medicine. 2005; 33: 112-3.
37. + T cell effector function in response to an intracellular pathogen. J Immunol. 2004; 172: 130-7.
38. Junqueira-Kipnis AP, Kipnis A, Jamieson A, et al. NK cells respond to pulmonary infection with Mycobacterium tuberculosis, but play a minimal role in protection. J Immunol. 2003; 171: 6039-45. http://www.medsci.org